Cerebrovascular disease treatment market is expected to grow at a considerable CAGR of 5.9% during the forecast period. The major factors that are augmenting the growth of the cerebrovascular disease treatment market are advancement in technology and increasing prevalence of strokes. Furthermore, expansion and spending on healthcare infrastructure in the emerging economies, favourable medical reimbursements are also estimated to be the major factors that are contributing significantly towards the growth of the market. Above 85.0% of the strokes are of ischemic stroke which makes it most commonly caused due to less blood supply to the brain. In addition to this, several government organizations play an important role in the growth of the market. For instance, in 2016, the Society of Vascular and Interventional Neurology (SVIN) started a health campaign of Mission Thrombectomy 2020 to accelerate the access of stroke treatment globally by doubling the normal rate of treatment by 2020. The stroke diseases require early treatment as it is can be life-threatening due to some delay in treatment.
However, the lack of awareness among the people, the absence of skilled neurosurgeons and diagnostic centers, and the high cost of cerebrovascular treatment are some of the restraints that can challenge the growth of the market in the forecast period. Conversely, the high growth rate in healthcare infrastructure and the increasing number of research in the field are the opportunities that are expected to fuel the cerebrovascular diseases treatment market.
To Request a Sample of our Report on Cerebrovascular Diseases Treatment Market: https://www.omrglobal.com/request-sample/cerebrovascular-diseases-treatment-market
By Type of Stroke
- Ischemic
- Haemorrhagic
By Treatment
- Medication
- Surgical Procedure
By End User
- Hospitals
- Surgical Clinics
- Research Institutions
A full Report of Cerebrovascular Diseases Treatment Market is Available @ https://www.omrglobal.com/industry-reports/cerebrovascular-diseases-treatment-market
Regional Analysis
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
Company Profiles
- Abbott Laboratories
- Amgen Inc.
- AstraZeneca plc
- Bayer AG
- Boehringer Ingelheim International GmbH
- Bristol-Myers Squibb Co.
- Daiichi Sankyo Co. Ltd.
- Hoffmann-La Roche Ltd.
- Genentech, Inc.
- Johnson & Johnson Services, Inc.
- Medtronic plc
- Merck & Co., Inc.
- Penumbra, Inc.
- Pfizer Inc.
- Sangamo Therapeutics, Inc.
- Sanofi SA
- Siemens Healthineers AG
- Sihuan Pharmaceutical Holdings Group Ltd.
- Takeda Pharmaceutical Co. Ltd.
- United Therapeutics Corp.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/cerebrovascular-diseases-treatment-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
